Farmer Melissa M, Stanislawski Maggie A, Plomondon Mary E, Bean-Mayberry Bevanne, Joseph Nataria T, Thompson Lauren E, Zuchowski Jessica L, Daugherty Stacie L, Yano Elizabeth M, Ho P Michael
1 VA HSR&D Center for the Study of Healthcare Innovation , Implementation & Policy, VA Greater Los Angeles Healthcare System, Sepulveda, California.
2 VA Eastern Colorado Health Care System , Denver, Colorado.
J Womens Health (Larchmt). 2017 Oct;26(10):1062-1068. doi: 10.1089/jwh.2016.6057. Epub 2017 May 12.
Advancements in percutaneous coronary intervention (PCI) for treating obstructive coronary artery disease have reduced major adverse events, including mortality. Yet, evidence as to whether women and men experience similar outcomes is mixed. The objective was to examine sex differences in 1-year major adverse cardiac outcomes for the national population of patients undergoing PCI at Veterans Health Administration (VA) cardiac catheterization laboratories.
All Veterans undergoing PCI at VA hospitals between October 1, 2007 and September 30, 2013 (N = 64,757; Women = 1,040) were included. Cox proportional hazards models compared 1-year postprocedural outcomes [rehospitalization for myocardial infarction (MI), all-cause mortality, and major adverse cardiovascular events (MACE)] by sex.
Women Veterans undergoing PCI were more likely to be younger, black, obese, and have chronic depression and less likely to have common cardiovascular risk factors and to have had prior cardiac events than Veteran men. One-year rates for women versus men were 2.1% and 2.5% for rehospitalization (p-value = 0.57); 3.5% and 4.9% for mortality (p-value = 0.14), and 5.4% and 6.9% for MACE (p-value = 0.18). There were no significant sex differences in any of the outcomes in Cox proportional hazards models.
Despite differences in clinical risk factors at the time of PCI, women and men Veterans treated at VA cardiac catheterization laboratories experienced comparable 1-year rehospitalization for MI, mortality, and MACE post-PCI. These results demonstrated similar 1-year post-PCI outcomes for men and women in a national population of patients who have more comorbidities and mental health issues than the general population.
经皮冠状动脉介入治疗(PCI)在治疗阻塞性冠状动脉疾病方面的进展已减少了包括死亡率在内的主要不良事件。然而,关于女性和男性是否有相似预后的证据并不一致。目的是研究在退伍军人健康管理局(VA)心脏导管实验室接受PCI的全国患者人群中,1年主要不良心脏结局的性别差异。
纳入2007年10月1日至2013年9月30日期间在VA医院接受PCI的所有退伍军人(N = 64,757;女性 = 1,040)。Cox比例风险模型按性别比较了术后1年的结局[因心肌梗死(MI)再次住院、全因死亡率和主要不良心血管事件(MACE)]。
接受PCI的退伍军人女性比男性更年轻、更可能是黑人、肥胖且患有慢性抑郁症,且比男性退伍军人更不太可能有常见的心血管危险因素和既往心脏事件。女性与男性的再次住院率分别为2.1%和2.5%(p值 = 0.57);死亡率分别为3.5%和4.9%(p值 = 0.14),MACE发生率分别为5.4%和6.9%(p值 = 0.18)。在Cox比例风险模型中,任何结局均无显著的性别差异。
尽管PCI时临床危险因素存在差异,但在VA心脏导管实验室接受治疗的退伍军人女性和男性在PCI术后1年因MI再次住院、死亡率和MACE方面经历相似。这些结果表明,在一个比普通人群有更多合并症和心理健康问题的全国患者人群中,男性和女性PCI术后1年的结局相似。